Beyond the Basics: PCOS and Its Impact on Fertility and Long-Term Health

Polycystic Ovary Syndrome (PCOS) is often discussed in terms of irregular periods, acne, and difficulty conceiving—but these surface-level symptoms only scratch the surface of what is, in truth, a complex and evolving condition. PCOS isn’t just about ovulation. It's a lifelong endocrine and metabolic syndrome that can impact everything from fertility to cardiovascular health, insulin sensitivity, and even mental wellbeing. And understanding how it changes over time is essential for women trying to conceive—especially those in their late 30s and 40s. 

PCOS Is Not One Size Fits All 

The first thing to know: PCOS is a syndrome, not a disease. That means it’s a collection of symptoms with multiple possible causes and presentations. Most clinicians still recognize four distinct phenotypes (A through D), but more recent genomic research suggests there may be just two truly distinct subtypes—one more classically “androgenic,” and one more “hypo-androgenic” that is especially relevant to older patients. 

Women in their teens and 20s with PCOS experience excess androgens (there are the male hormones such as testosterone), irregular periods, and difficulty ovulating. But for some women—particularly those in the D phenotype—these androgen levels actually decline as they age. After 35, those PCOS patients demonstrate too low androgens, which are essential for healthy follicle development and egg quality. These patients usually present with regular cycles and lean body types—making them easy to misdiagnose or overlook entirely. 

The Fertility Connection: It’s Not Just About Ovulation 

While PCOS is the most common cause of anovulatory infertility, many women are surprised to learn that the story doesn’t end with ovulation induction. In fact, even women who ovulate regularly can struggle with egg quality, implantation, or hormonal imbalances related to PCOS—especially as they approach their late 30s and early 40s.  

As ovarian reserve naturally declines with age, PCOS adds another layer of complexity. Certain phenotypes are at increased risk of developing low androgen levels (hypoandrogenism), which can further impair egg quality and IVF outcomes. In these cases, androgen supplementation with DHEA may improve ovarian response—but only when carefully monitored by fertility specialists who understand the nuances of PCOS in older patients. 

Rethinking Treatment at 35+ 

For women over 35, especially those trying to conceive, treatment must be more targeted. Inositol—often recommended as a blanket supplement for all PCOS patients—can actually lower already-declining androgen levels in D-phenotype patients, potentially doing more harm than good. 

At the Center for Human Reproduction (CHR), we take a personalized approach to PCOS. Our team regularly sees patients who were misdiagnosed or poorly treated by conventional standards because they didn’t fit the “typical” PCOS picture. We believe understanding the underlying hormonal and genomic differences is key to guiding smarter, more effective care. 

The Bottom Line 

PCOS is more than a reproductive disorder. It’s a dynamic condition that can evolve with age—and so should your treatment. Whether you’re in your 20s or 40s, understanding your specific PCOS phenotype, hormone profile, and long-term risks can empower you to make better choices for your health and fertility. 

If you're navigating PCOS and want a more personalized, evidence-based approach, we invite you to schedule a consultation with our team.